1. FRI0240 Rheumatoid arthritis (RA) impact following treatment with sarilumab: patient reported outcomes using the raid scale from two randomized phase III trials. (15th June 2017) Authors: Gossec, L; Strand, V; Proudfoot, C; Chen, C; Guillonneau, S; Kimura, T; Hoogstraten, H van; Mangan, E; Reaney, M Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 575 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. FRI0242 Association between clinical and radiographic responses, and physical function in a phase 3 study of sarilumab plus methotrexate in patients with active, moderate-to-severe rheumatoid arthritis. (15th June 2017) Authors: Genovese, MC; Hoogstraten, H van; Kampman, W; Jayawardena, S; Huizinga, TW Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 576 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. OP0102 Patient reported benefits of sarilumab monotherapy versus adalimumab monotherapy in adult patients with active rheumatoid arthritis. (15th June 2017) Authors: Strand, V; Gossec, L; Proudfoot, C; Chen, C; Reaney, M; Guillonneau, S; Kimura, T; Adelsberg, J van; Lin, Y; Mangan, E; Hoogstraten, H van; Burmester, GR Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 94 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. SAT0180 Efficacy and safety of sarilumab 200 MG Q2W administered as combination therapy or monotherapy in different patient populations with active RA. (15th June 2017) Authors: Genovese, MC; Fleischmann, R; Hoogstraten, H van; Mangan, EK; Jayawardena, S; Burmester, GR Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 838 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. SAT0202 Efficacy and safety of sarilumab monotherapy versus adalimumab monotherapy in patients with active rheumatoid arthritis in the phase 3 monarch study, including subpopulations. (15th June 2017) Authors: Burmester, GR; Lin, Y; Mangan, EK; Hoogstraten, H van; Kimura, T; Vargas, JI; Lee, EB Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 849 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. SAT0212 Sarilumab dose reduction in an open-label extension study in ra patients with inadequate response to tnf inhibitors. (15th June 2017) Authors: Fleischmann, R; Hrycaj, P; Hoogstraten, H van; Mangan, EK; Lin, Y; Jayawardena, S; Burmester, GR Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 853 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗